With this approach, it has been demonstrated that the epidermal growth factor receptor (EGFR) plays an important role in the diagnosis and follow-up of lung cancer, and that mutations in the EGFR gene can be used as biomarkers. The gene discussed is EGFR; the disease is lung carcinoma.